The cause of a rare, inherited, often fatal kidney disease in many patients remained elusive for years, despite multiple attempts to solve the mystery. Then in 2012, a team of researchers cracked some of the unsolved cases in just six weeks.

Novartis is developing an experimental drug for weight loss.

Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.

Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.

Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.

Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.

Novartis has launched a comprehensive research program to help find the right combinations of therapies for the right patients.

Inspired by her mother, Vicky Qi leads drug discovery teams.

Lazala has been recognized by Hispanic Executive magazine for her commitment to mentoring students and colleagues.

Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.